TrialThe Journal of infection2023

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.

Robert H Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.